Director Robert Chapin receives 1,268-share stock grant at NHI (NHI)
Rhea-AI Filing Summary
National Health Investors director Robert Chapin reported an equity award of common stock. He acquired 1,268 shares of restricted stock on March 3, 2026 at no purchase price as a grant for board service. The award vests in full on March 3, 2027, provided he continues serving as a director through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,268 shares
Net Buy
1 txn
Insider
Chapin Robert
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,268 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 1,268 shares (Direct)
Footnotes (1)
- F1. Represents a grant of restricted stock awarded on March 3, 2026, which vests in full on March 3, 2027, subject to the reporting person's continued service as a director through such date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did director Robert Chapin acquire in the latest NHI Form 4 filing?
Director Robert Chapin received a grant of 1,268 shares of National Health Investors common stock as restricted stock. The award represents equity-based compensation for board service and was reported as an acquisition under a grant or award transaction code.
What transaction code is used for Robert Chapin’s NHI stock grant?
The transaction is reported with code “A”, described as a grant, award, or other acquisition. This indicates the shares were received as restricted stock compensation rather than through a traditional stock purchase or sale transaction.